As of 2026-09-26, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 1.12 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -2.90 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 5.7x | 3.4x |
| Forward P/E multiples | 0.5x - 1.5x | 0.7x |
| Fair Price | (0.05) - (0.04) | (0.05) |
| Upside | -598.2% - -457.5% | -590.9% |
| Date | EV/EBITDA |
| 2026-09-16 | -0.39 |
| 2026-09-11 | -0.18 |
| 2026-09-10 | -0.18 |
| 2026-08-26 | -0.18 |
| 2026-08-21 | -0.39 |
| 2026-08-12 | -0.39 |
| 2026-08-07 | -0.39 |
| 2026-07-20 | -0.39 |
| 2026-07-17 | -0.39 |
| 2026-07-15 | -0.18 |
| 2026-07-03 | -0.39 |
| 2026-06-30 | -0.39 |
| 2026-06-29 | -0.39 |